The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA -Related Cancer: US Preventive Services Task Force Recommendation Statement
Open accessAbstract
Importance: Potentially harmful mutations of the breast cancer susceptibility 1 and 2 genes (BRCA1/2) are associated with increased risk for breast, ovarian, fallopian tube, and peritoneal cancer. For women in the United States, breast cancer is the most common cancer after nonmelanoma skin cancer and the second leading cause of cancer death. In the general population, BRCA1/2 mutations occur in an estimated 1 in 300 to 500 women and account for 5% to 10% of breast cancer cases and 15% of ovarian cancer cases. Objective: To update the 2013 US Preventive Services Task Force (USPSTF) recommendation on risk assessment, genetic counseling, and genetic testing for BRCA-related cancer. Evidence Review: The USPSTF reviewed the evidence on risk assessment, genetic counseling, and genetic testing for potentially harmful BRCA1/2 mutations in asymptomatic women who have never been diagnosed with BRCA-related cancer, as well as those with a previous diagnosis of breast, ovarian, tubal, or peritoneal cancer who have completed treatment and are considered cancer free. In addition, the USPSTF reviewed interventions to reduce the risk for breast, ovarian, tubal, or peritoneal cancer in women with potentially harmful BRCA1/2 mutations, including intensive cancer screening, medications, and risk-reducing surgery. Findings: For women whose family or personal history is associated with an increased risk for harmful mutations in the BRCA1/2 genes, or who have an ancestry associated with BRCA1/2 gene mutations, there is adequate evidence that the benefits of risk assessment, genetic counseling, genetic testing, and interventions are moderate. For women whose personal or family history or ancestry is not associated with an increased risk for harmful mutations in the BRCA1/2 genes, there is adequate evidence that the benefits of risk assessment, genetic counseling, genetic testing, and interventions are small to none. Regardless of family or personal history, the USPSTF found adequate evidence that the overall harms of risk assessment, genetic counseling, genetic testing, and interventions are small to moderate. Conclusions and Recommendation: The USPSTF recommends that primary care clinicians assess women with a personal or family history of breast, ovarian, tubal, or peritoneal cancer or who have an ancestry associated with BRCA1/2 gene mutations with an appropriate brief familial risk assessment tool. Women with a positive result on the risk assessment tool should receive genetic counseling and, if indicated after counseling, genetic testing. (B recommendation) The USPSTF recommends against routine risk assessment, genetic counseling, or genetic testing for women whose personal or family history or ancestry is not associated with potentially harmful BRCA1/2 gene mutations. (D recommendation).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
A Strong Candidate for the Breast and Ovarian Cancer Susceptibility Gene BRCA1
Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, L. M., Ding, W., et al. (1994) · Science · doi:10.1126/science.7545954 · Cited by 6,071
Antoniou, A., Pharoah, P. D. P., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, Å., et al. (2003) · The American Journal of Human Genetics · doi:10.1086/375033 · Cited by 3,680
The National Comprehensive Cancer Network (NCCN).
Wood, E. H. (2004) · Journal of the Medical Library Association JMLA · Cited by 2,845
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
Domchek, S. M. (2010) · JAMA · doi:10.1001/jama.2010.1237 · Cited by 1,494
(2006) · Cancer · doi:10.1002/(issn)1097-0142 · Cited by 1,470
Prophylactic Oophorectomy in Carriers of BRCA1 or BRCA2 Mutations
Rebbeck, T. R., Lynch, H. T., Neuhausen, S. L., Narod, S. A., van't Veer, L., Garber, J. E., Evans, G., Isaacs, C., Daly, M. B., Matloff, E., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012158 · Cited by 1,465
Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer
Hartmann, L. C., Schaid, D. J., Woods, J. E., Crotty, T. P., Myers, J. L., Arnold, P. G., Petty, P. M., Sellers, T. A., Johnson, J. L., McDonnell, S. K., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400201 · Cited by 1,423
Fisher, B., Costantino, J. P., Wickerham, D. L., Cecchini, R. S., Cronin, W. M., Robidoux, A., Bevers, T. B., Kavanah, M. T., Atkins, J. N., Margolese, R. G., et al. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji372 · Cited by 1,339
Exemestane for Breast-Cancer Prevention in Postmenopausal Women
Goss, P. E., Ingle, J. N., Alés-Martínez, J. E., Cheung, A. M., Chlebowski, R. T., Wactawski-Wende, J., McTiernan, A., Robbins, J., Johnson, K. C., Martin, L. W., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103507 · Cited by 970
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
Mavaddat, N., Peock, S., Frost, D., Ellis, S., Platte, R., Fineberg, E., Evans, D. G., Izatt, L., Eeles, R. A., Adlard, J., et al. (2013) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djt095 · Cited by 951
Prevalence of BRCA1 and BRCA2 Gene Mutations in Patients With Early-Onset Breast Cancer
Peto, J., Collins, N., Barfoot, R., Seal, S., Warren, W., Rahman, N., Easton, D. F., Evans, C., Deacon, J., & Stratton, M. R. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.11.943 · Cited by 873
Lerman, C. (1996) · JAMA · doi:10.1001/jama.1996.03530480027036 · Cited by 792
Efficacy of Bilateral Prophylactic Mastectomy in BRCA1 and BRCA2 Gene Mutation Carriers
Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., Frost, M. H., Grant, C. S., Donohue, J. H., Woods, J. E., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.21.1633 · Cited by 743
Vogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., Cecchini, R. S., Atkins, J. N., Bevers, T. B., Fehrenbacher, L., Pajon, E. R., Wade, J. L., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0076 · Cited by 646
Wooster, R., & Weber, B. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012284 · Cited by 605
(2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1407 · Cited by 604
Cuzick, J., Sestak, I., Forbes, J. F., Dowsett, M., Knox, J., Cawthorn, S., Saunders, C., Roche, N., Mansel, R. E., von Minckwitz, G., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62292-8 · Cited by 590
Cuzick, J., Forbes, J. F., Sestak, I., Cawthorn, S., Hamed, H., Holli, K., & Howell, A. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk049 · Cited by 534
American Journal of Medical Genetics
(2006) · American Journal of Medical Genetics · doi:10.1002/(issn)1096-8628 · Cited by 516
Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian
Mersch, J., Jackson, M. A., Park, M., Nebgen, D., Peterson, S. K., Singletary, C., Arun, B. K., & Litton, J. K. (2015) · Cancer · doi:10.1002/cncr.29041 · Cited by 511
A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes
Antoniou, A. C., Pharoah, P. D. P., McMullan, G., Day, N. E., Stratton, M. R., Peto, J., Ponder, B. J., & Easton, D. F. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600008 · Cited by 495
(1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.5.1730 · Cited by 484
Armstrong, K. (2005) · JAMA · doi:10.1001/jama.293.14.1729 · Cited by 432
Powles, T. J., Ashley, S., Tidy, A., Smith, I. E., & Dowsett, M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk050 · Cited by 430
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2014) · Annals of Internal Medicine · doi:10.7326/m13-2747 · Cited by 409
U.S. Preventive Services Task Force* (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-5-200509060-00011 · Cited by 405
Self-citationPaluch-Shimon, S., Cardoso, F., Sessa, C., Balmana, J., Cardoso, M. J., Gilbert, F., & Senkus, E. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw327 · Cited by 399
Nelson, H. D., Pappas, M., Zakher, B., Mitchell, J. P., Okinaka-Hu, L., & Fu, R. (2014) · Annals of Internal Medicine · doi:10.7326/m13-1684 · Cited by 319
Lancaster, J. M., Powell, C. B., Chen, L.-M., & Richardson, D. L. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.09.009 · Cited by 298
BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer
Petrucelli, N., Daly, M. B., & Pal, T. (2016) · Europe PMC (PubMed Central) · Cited by 294
Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Grossman, D. C., Curry, S. J., Owens, D. K., Barry, M. J., Davidson, K. W., Doubeni, C. A., Epling, J. W., Kemper, A. R., Krist, A. H., et al. (2018) · JAMA · doi:10.1001/jama.2017.21926 · Cited by 283
Self-citationEvans, D. G. R., Eccles, D. M., Rahman, N., Young, K., Bulman, M., Amir, E., Shenton, A., Howell, A., & Lalloo, F. (2004) · Journal of Medical Genetics · doi:10.1136/jmg.2003.017996 · Cited by 265
Brandberg, Y., Sandelin, K., Erikson, S., Jurell, G., Liljegren, A., Lindblom, A., Lindén, A., von Wachenfeldt, A., Wickman, M., & Arver, B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.9568 · Cited by 265
Veronesi, U., Maisonneuve, P., Rotmensz, N., Bonanni, B., Boyle, P., Viale, G., Costa, A., Sacchini, V., Travaglini, R., D'Aiuto, G., et al. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk154 · Cited by 242
Watson, M., Lloyd, S., Davidson, J., Meyer, L., Eeles, R., Ebbs, S., & Murday, V (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690139 · Cited by 241
Bourne, T. H., Campbell, S., Reynolds, K. M., Whitehead, M. I., Hampson, J., Royston, P., Crayford, T. J., & Collins, W. P. (1993) · BMJ · doi:10.1136/bmj.306.6884.1025 · Cited by 240
Heemskerk-Gerritsen, B. A. M., Seynaeve, C., van Asperen, C. J., Ausems, M. G. E. M., Collée, J. M., van Doorn, H. C., Gomez Garcia, E. B., Kets, C. M., van Leeuwen, F. E., Meijers-Heijboer, H. E. J., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djv033 · Cited by 206
Finch, A., Metcalfe, K. A., Chiang, J. K., Elit, L., McLaughlin, J., Springate, C., Demsky, R., Murphy, J., Rosen, B., & Narod, S. A. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2010.12.326 · Cited by 200
Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
Kotsopoulos, J., Huzarski, T., Gronwald, J., Singer, C. F., Moller, P., Lynch, H. T., Armel, S., Karlan, B., Foulkes, W. D., Neuhausen, S. L., et al. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw177 · Cited by 197
Antoniou, A. C., Hardy, R., Walker, L., Evans, D. G., Shenton, A., Eeles, R., Shanley, S., Pichert, G., Izatt, L., Rose, S., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2007.056556 · Cited by 194
Risk models for familial ovarian and breast cancer
Antoniou, A. C., Gayther, S. A., Stratton, J. F., Ponder, B. A. J., & Easton, D. F. (2000) · Genetic Epidemiology · Cited by 192
Nelson, H. D., Smith, M. E. B., Griffin, J. C., & Fu, R. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-158-8-201304160-00005 · Cited by 187
Prophylactic oophorectomy in inherited breast/ovarian cancer families.
Struewing, J. P., Watson, P., Easton, D., Ponder, B. A. J., Lynch, H. T., & Tucker, M. A. (1995) · PubMed · Cited by 184
Lerman, C., Schwartz, M. D., Miller, S. M., Daly, M., Sands, C., & Rimer, B. K. (1996) · Health Psychology · doi:10.1037//0278-6133.15.2.75 · Cited by 181
Predictors of and Satisfaction with Bilateral Prophylactic Mastectomy
Stefanek, M. E., Helzlsouer, K. J., Wilcox, P. M., & Houn, F. (1995) · Preventive Medicine · doi:10.1006/pmed.1995.1066 · Cited by 177
Nelson, H. D., Pappas, M., Cantor, A. G., Haney, E. M., & Holmes, R. S. (2019) · JAMA · doi:10.1001/jama.2019.8430 · Cited by 170
Breast Cancer Susceptibility Genes: BRCA1 and BRCA2
Brody, L. C., & Biesecker, B. B. (1998) · Medicine · doi:10.1097/00005792-199805000-00006 · Cited by 163
Hermsen, B. B. J., Olivier, R. I., Verheijen, R. H. M., van Beurden, M., de Hullu, J. A., Massuger, L. F. A. G., Burger, C. W., Brekelmans, C. T. M., Mourits, M. J. E., de Bock, G. H., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603725 · Cited by 155
Heemskerk-Gerritsen, B. A. M., Brekelmans, C. T. M., Menke-Pluymers, M. B. E., van Geel, A. N., Tilanus-Linthorst, M. M. A., Bartels, C. C. M., Tan, M., Meijers-Heijboer, H. E. J., Klijn, J. G. M., & Seynaeve, C. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9449-x · Cited by 153
Pirl (2000) · doi:10.1002/(issn)1099-1611 · Cited by 150
Gahm, J., Wickman, M., & Brandberg, Y. (2010) · The Breast · doi:10.1016/j.breast.2010.05.003 · Cited by 146
Heemskerk‐Gerritsen, B. A. M., Menke‐Pluijmers, M. B. E., Jager, A., Tilanus‐Linthorst, M. M. A., Koppert, L. B., Obdeijn, I. M., van Deurzen, C. H. M., Collée, J. M., Seynaeve, C., & Hooning, M. J. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt134 · Cited by 141
Validity of Models for Predicting BRCA1 and BRCA2 Mutations
Parmigiani, G., Chen, S., Iversen, E. S., Friebel, T. M., Finkelstein, D. M., Anton-Culver, H., Ziogas, A., Weber, B. L., Eisen, A. F., Malone, K. E., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-7-200710020-00002 · Cited by 140
Lerman, C., Hughes, C., Benkendorf, J., Biesecker, B. B., Kerner, J. F., Willison, J., Eads, N. L., Hadley, D. W., & Lynch, J. W. (1999) · PubMed · Cited by 140
Lobb, E. A., Butow, P. N., Barratt, A. L., Meiser, B., Gaff, C., Young, M., Haan, E., Suthers, G., Gattas, M. R., & Tucker, K. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6601502 · Cited by 138
Sherman, M. E., PIEDMONTE, M. R., Mai, P. L., Ioffe, O. B., Ronnett, B. M., Le, L. V., Ivanov, I., Bell, M. C., Blank, S. V., DiSilvestro, P., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.54.1987 · Cited by 138
Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients
Lumish, H. S., Steinfeld, H., Koval, C., Russo, D., Levinson, E., Wynn, J., Duong, J. K., & Chung, W. K. (2017) · Journal of Genetic Counseling · doi:10.1007/s10897-017-0090-y · Cited by 138
Nelson, H. D., Fu, R., Zakher, B., Pappas, M., & McDonagh, M. (2019) · JAMA · doi:10.1001/jama.2019.5780 · Cited by 137
Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy
Metcalfe, K., Esplen, M., Goel, V., & Narod, S. (2004) · Psycho-Oncology · doi:10.1002/pon.726 · Cited by 136
Manchanda, R., Loggenberg, K., Sanderson, S., Burnell, M., Wardle, J., Gessler, S., Side, L., Balogun, N., Desai, R., Kumar, A., et al. (2015) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju379 · Cited by 135
Family history of breast cancer: what do women understand and recall about their genetic risk?
Watson, M., Duvivier, V., Walsh, M. W., Ashley, S., Davidson, J. M., Papaikonomou, M., Murday, V. A., Sacks, N., & Eeles, R. A. (1998) · Journal of Medical Genetics · doi:10.1136/jmg.35.9.731 · Cited by 135
Kramer, J. L., Velazquez, I. A., Chen, B. E., Rosenberg, P. S., Struewing, J. P., & Greene, M. H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.9199 · Cited by 135
Gopie, J. P., Mureau, M. A. M., Seynaeve, C., ter Kuile, M. M., Menke‐Pluymers, M. B. E., Timman, R., & Tibben, A. (2012) · Familial Cancer · doi:10.1007/s10689-012-9588-5 · Cited by 127
Psychological impact of genetic testing in women from high-risk breast cancer families
Meiser, B., Butow, P. N., Friedlander, M. L., Barratt, A. L., Schnieden, V., Watson, M., Brown, J. K., & Tucker, K. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00264-2 · Cited by 127
A Systematic Review of the Impact of Genetic Counseling on Risk Perception Accuracy
Smerecnik, C. M. R., Mesters, I., Verweij, E., de Vries, N. K., & de Vries, H. (2009) · Journal of Genetic Counseling · doi:10.1007/s10897-008-9210-z · Cited by 125
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-10-201311190-00718 · Cited by 125
Prevalence of BRCA1 Mutation Carriers among U.S. Non-Hispanic Whites
Whittemore, A. S., Gong, G. D., John, E. M., McGuire, V. M., Li, F. P., Ostrow, K. L., DiCioccio, R. A., Felberg, A., & West, D. W. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.2078.13.12 · Cited by 124
The use of videotaped information in cancer genetic counselling: a randomized evaluation study
Cull, A., Miller, H., Porterfield, T., Mackay, J., Anderson, E., Steel, C., & Elton, R. (1998) · British Journal of Cancer · doi:10.1038/bjc.1998.135 · Cited by 123
Smith, K. R., West, J. A., Croyle, R. T., & Botkin, J. R. (1999) · PubMed · Cited by 120
Evaluation of a breast/ovarian cancer genetics referral screening tool in a mammography population
Bellcross, C. A., Lemke, A. A., Pape, L. S., Tess, A., & Meisner, L. T. (2009) · Genetics in Medicine · doi:10.1097/gim.0b013e3181b9b04a · Cited by 118
Gilpin, C., Carson, N. L., & Hunter, A. (2000) · Clinical Genetics · doi:10.1034/j.1399-0004.2000.580408.x · Cited by 115
Norquist, B. M., Garcia, R. L., Allison, K. H., Jokinen, C. H., Kernochan, L. E., Pizzi, C. C., Barrow, B. J., Goff, B. A., & Swisher, E. M. (2010) · Cancer · doi:10.1002/cncr.25439 · Cited by 108
Le‐Petross, H. T., Whitman, G. J., Atchley, D. P., Yuan, Y., Gutierrez‐Barrera, A. M., Hortobágyi, G. N., Litton, J. K., & Arun, B. (2011) · Cancer · doi:10.1002/cncr.25971 · Cited by 105
Systematic Review: Comparative Effectiveness of Medications to Reduce Risk for Primary Breast Cancer
Nelson, H. D., Fu, R., Griffin, J. C., Nygren, P., Smith, M. E. B., & Humphrey, L. (2009) · Annals of Internal Medicine · doi:10.7326/0000605-200911170-00147 · Cited by 102
Isern, A. E., Tengrup, I., Loman, N., Olsson, H. L., & Ringberg, A. (2007) · Journal of Plastic Reconstructive & Aesthetic Surgery · doi:10.1016/j.bjps.2007.08.006 · Cited by 100
Assessing BRCA Carrier Probabilities in Extended Families
Barcenas, C. H., Hosain, G. M., Arun, B. K., Zong, J., Zhou, X., Chen, J., Cortada, J. M., Mills, G. B., Tomlinson, G. E., Miller, A. R., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.2368 · Cited by 100
Hoskins, K. F., Zwaagstra, A., & Ranz, M. (2006) · Cancer · doi:10.1002/cncr.22202 · Cited by 99
Fischer, C., Kuchenbäcker, K., Engel, C., Zachariae, S., Rhiem, K., Meindl, A., Rahner, N., Dikow, N., Plendl, H., Debatin, I., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101415 · Cited by 94
Ashton‐Prolla, P., Giacomazzi, J., Schmidt, A. V., Roth, F. L., Palmero, E. I., Kalakun, L., de Aguiar, E. S., Moreira, S. M., Batassini, É., Reyes, V. B., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-283 · Cited by 94
van Dijk, S., Timmermans, D. R. M., Meijers-Heijboer, H. E. J., Tibben, A., van Asperen, C. J., & Otten, W. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.7259 · Cited by 94
Moyer, V. A. (2013) · Annals of Internal Medicine · doi:10.7326/0003-4819-159-10-201311190-00717 · Cited by 92
US Preventive Services Task Force, Bibbins-Domingo, K. B., Grossman, D. C., Curry, S. J., Barry, M. J., Davidson, K. W., Doubeni, C. A., Epling, J. W., García, F., Kemper, A. R., et al. (2017) · JAMA · doi:10.1001/jama.2017.0807 · Cited by 92
Self-citationPatients’ Resistance to Risk Information in Genetic Counseling for BRCA1/2
Gurmankin, A. D., Domchek, S. M., Stopfer, J., Fels, C., & Armstrong, K. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.5.523 · Cited by 90
Metcalfe, K. A., Mian, N., Enmore, M., Poll, A., Llacuachaqui, M., Nanda, S., Sun, P., Hughes, K. S., & Narod, S. A. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1941-0 · Cited by 88
den Heijer, M., Seynaeve, C., Timman, R., Duivenvoorden, H. J., Vanheusden, K., Tilanus‐Linthorst, M. M. A., Menke‐Pluijmers, M. B. E., & Tibben, A. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.10.020 · Cited by 88
Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three-year follow-up
Foster, C., Watson, M., Eeles, R., Eccles, D., Ashley, S., Davidson, R., Mackay, J., Morrison, P., Hopwood, P., & Evans, D. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603610 · Cited by 87
Risk reducing mastectomy: outcomes in 10 European centres
Evans, D. G., Baildam, A. D., Anderson, E. D. C., Brain, A., Shenton, A., Vasen, H. F. A., Eccles, D., Lucassen, A., Pichert, G., Hamed, H., et al. (2008) · Journal of Medical Genetics · doi:10.1136/jmg.2008.062232 · Cited by 87
Genetic counseling for women with an intermediate family history of breast cancer
Burke, W., Culver, J. O., Bowen, D. J., Lowry, D. K., Durfy, S. J., McTiernan, A., & Andersen, M. R. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000228)90:5<361::aid-ajmg4>3.0.co;2-8 · Cited by 86
Finch, A., & Narod, S. A. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.08.001 · Cited by 83
Kriege, M., Brekelmans, C. T. M., Boetes, C., Muller, S. H., Zonderland, H. M., Obdeijn, I. M., Manoliu, R. A., Kok, T., Rutgers, E. J. T., de Koning, H. J., et al. (2006) · Cancer · doi:10.1002/cncr.21863 · Cited by 81
Breast cancer after bilateral risk-reducing mastectomy
Skytte, A., Crüger, D. G., Gerster, M., Lænkholm, A., Lang, C., Brøndum‐Nielsen, K., Andersen, M., Sunde, L., Kølvraa, S., & Gerdes, A. (2011) · Clinical Genetics · doi:10.1111/j.1399-0004.2010.01604.x · Cited by 76
Arver, B. W., Haegermark, A., Platten, U., Lindblom, A., & Brandberg, Y. (2004) · Familial Cancer · doi:10.1023/b:fame.0000039863.89137.f9 · Cited by 74
Reichelt, J. G., Heimdal, K., Møller, P., & Dahl, A. A. (2004) · Familial Cancer · doi:10.1023/b:fame.0000026820.32469.4a · Cited by 73
Lippman, M. E., Cummings, S. R., Disch, D. P., Mershon, J. L., Dowsett, S. A., Cauley, J. A., & Martino, S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0688 · Cited by 73
Bilateral Prophylactic Mastectomy in Swedish Women at High Risk of Breast Cancer: A National Survey
Arver, B. W., Isaksson, K., Atterhem, H., Baan, A., Bergkvist, L., Brandberg, Y., Ehrencrona, H., Emanuelsson, M., Hellborg, H., Henriksson, K. M., et al. (2011) · Annals of Surgery · doi:10.1097/sla.0b013e318214b55a · Cited by 72
Šestak, I., Singh, S., Cuzick, J. M., Blake, G. M., Patel, R., Gossiel, F., Coleman, R. E., Dowsett, M., Forbes, J., Howell, A., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)71035-6 · Cited by 71
Reduced Incidence of Invasive Breast Cancer With Raloxifene Among Women at Increased Coronary Risk
Grady, D. L., Cauley, J. A., Geiger, M. J., Kornitzer, M., Mosca, L. J., Collins, P., WENGER, N. K., Song, J., Mershon, J. L., Barrett-Connor, E. L., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn153 · Cited by 70
Selecting a BRCA risk assessment model for use in a familial cancer clinic
Panchal, S., Ennis, M., Cañón, S. C. M., & Bordeleau, L. J. (2008) · BMC Medical Genetics · doi:10.1186/1471-2350-9-116 · Cited by 69
Results of a randomized study of telephone versus in-person breast cancer risk counseling
Helmes, A. W., Culver, J. O., & Bowen, D. J. (2006) · Patient Education and Counseling · doi:10.1016/j.pec.2005.12.002 · Cited by 66
Breast cancer risk counseling improves women’s functioning
Bowen, D. J., Burke, W., McTiernan, A., Yasui, Y., & Andersen, M. R. (2003) · Patient Education and Counseling · doi:10.1016/s0738-3991(03)00122-8 · Cited by 64
Bresser, P. J. C., Seynaeve, C., Gool, A. R. V., Niermeijer, M. F., Duivenvoorden, H. J., van Dooren, S., van Geel, A. N., Menke‐Pluijmers, M. B. E., Klijn, J. G. M., & Tibben, A. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.09.009 · Cited by 63
Matloff, E. T., Moyer, A. E., Shannon, K. M., Niendorf, K. B., & Col, N. F. (2006) · Journal of Women s Health · doi:10.1089/jwh.2006.15.843 · Cited by 60
Maunsell, E., Goss, P. E., Chlebowski, R. T., Ingle, J. N., Alés‐Martínez, J. E., Sarto, G. E., Fabian, C. J., Pujol, P., Ruiz, A., Cooke, A. L., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.51.2483 · Cited by 54
Psychological Factors Associated with Emotional Responses to Receiving Genetic Risk Information
Bennett, P. D., Wilkinson, C., Turner, J., Brain, K. E., Edwards, R. T., Griffith, G. L., France, B., & Gray, J. R. (2008) · Journal of Genetic Counseling · doi:10.1007/s10897-007-9136-x · Cited by 53
Benefit Finding in Response to BRCA1/2 Testing
Low, C. A., Bower, J. E., Kwan, L. C., & Seldon, J. L. (2008) · Annals of Behavioral Medicine · doi:10.1007/s12160-007-9004-9 · Cited by 49
Julian‐Reynier, C., Mancini, J., Mouret‐Fourme, E., Gauthier‐Villars, M., Bonadona, V., Berthet, P., Fricker, J., Caron, O., Luporsi, É., & Noguès, C. (2011) · European Journal of Human Genetics · doi:10.1038/ejhg.2010.241 · Cited by 49
Geirdal, A. Ø., Reichelt, J. G., Dahl, A. A., Heimdal, K., Mæhle, L., Stormorken, A. T., & Møller, P. (2005) · Familial Cancer · doi:10.1007/s10689-004-7995-y · Cited by 48
Andrews, L., Meiser, B., Apicella, C., & Tucker, K. (2004) · Genetic Testing · doi:10.1089/gte.2004.8.240 · Cited by 47
Roshanai, A. H., Rosenquist, R., Lampic, C., & Nordin, K. (2009) · Acta Oncologica · doi:10.1080/02841860903104137 · Cited by 47
Spagnolo, F., Šestak, I., Howell, A., Forbes, J., & Cuzick, J. M. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.4972 · Cited by 47
Flippo-Morton, T. S., Walsh, K. K., Chambers, K. M., Amacker-North, L., White, B., Sarantou, T., Boselli, D. M., & White, R. L. (2015) · The Breast Journal · doi:10.1111/tbj.12521 · Cited by 45
Kast, K., Schmutzler, R. K., Rhiem, K., Kiechle, M. B., Fischer, C., Niederacher, D., Arnold, N., Grimm, T., Speiser, D., Schlegelberger, B., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.28875 · Cited by 43
Psychological impact of recall on women with BRCA mutations undergoing MRI surveillance
Spiegel, T. N., Esplen, M. J., Hill, K. A., Wong, J., Causer, P. A., & Warner, E. (2011) · The Breast · doi:10.1016/j.breast.2011.04.004 · Cited by 41
Self-citation(2015) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000466373.71146.51 · Cited by 40
Wasteson, E., Sandelin, K., Brandberg, Y., Wickman, M., & Arver, B. W. (2010) · European Journal of Cancer Care · doi:10.1111/j.1365-2354.2010.01204.x · Cited by 38
Borreani, C., Manoukian, S., Bianchi, E., Brunelli, C., Peissel, B., Caruso, A., Morasso, G., & Pierotti, M. A. (2014) · Clinical Genetics · doi:10.1111/cge.12298 · Cited by 38
Effects of risk counseling on interest in breast cancer genetic testing for lower risk women
Bowen, D. J., Burke, W., Yasui, Y., McTiernan, A., & McLeran, D. (2002) · Genetics in Medicine · doi:10.1097/00125817-200209000-00007 · Cited by 38
Lieberman, S., Tomer, A., Ben-Chetrit, A., Olsha, O., Strano, S., Beeri, R., Koka, S., Fridman, H., Djemal, K., Glick, I., et al. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0734-4 · Cited by 38
Livaudais‐Toman, J., Karliner, L., Tice, J. A., Kerlikowske, K. M., Gregorich, S. E., Pérez‐Stable, E. J., Pasick, R. J., Chen, A. P., Quinn, J., & Kaplan, C. P. (2015) · The Breast · doi:10.1016/j.breast.2015.09.009 · Cited by 37
Bilateral oophorectomy and breast cancer risk reduction among women with a family history
Olson, J. E., Sellers, T. A., Iturria, S. J., & Hartmann, L. C. (2004) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2004.03.003 · Cited by 37
Pieterse, A. H., Ausems, M. G. E. M., Spreeuwenberg, P. M. M., & van Dulmen, S. (2011) · Patient Education and Counseling · doi:10.1016/j.pec.2011.01.017 · Cited by 37
Reichelt, J. G., Møller, P., Heimdal, K., & Dahl, A. A. (2008) · Familial Cancer · doi:10.1007/s10689-008-9182-z · Cited by 36
Oros, K., Ghadirian, P., Maugard, C. M., Perret, C., Paredes, Y., Mes‐Masson, A., Foulkes, W. D., Provencher, D. M., & Tonin, P. N. (2006) · Clinical Genetics · doi:10.1111/j.1399-0004.2006.00673.x · Cited by 36
Brandberg, Y., Arver, B. W., Johansson, H., Wickman, M., Sandelin, K., & Liljegren, A. (2011) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2011.10.010 · Cited by 36
Development of a risk assessment tool for women with a family history of breast cancer
Braithwaite, D., Sutton, S. R., Mackay, J., Stein, J., & Emery, J. D. (2005) · Cancer Detection and Prevention · doi:10.1016/j.cdp.2005.06.001 · Cited by 35
Shah, P. D., Rosen, M. A., Stopfer, J. E., Siegfried, J. D., Kaltman, R. D., Mason, B. A., Armstrong, K., Nathanson, K. L., Schnall, M. D., & Domchek, S. M. (2009) · Breast Cancer Research and Treatment · doi:10.1007/s10549-009-0475-1 · Cited by 34
Michelsen, T. M., Dørum, A., Trope, C. G., Fosså, S. D., & Dahl, A. A. (2009) · International Journal of Gynecological Cancer · doi:10.1111/igc.0b013e3181a83cd5 · Cited by 31
Effects of a telephone counseling intervention on sisters of young women with breast cancer
Bloom, J. R., STEWART, S. L., Chang, S. M., & You, M. (2006) · Preventive Medicine · doi:10.1016/j.ypmed.2006.07.002 · Cited by 31
Noh (2006) · doi:10.1002/(issn)1098-2272 · Cited by 25
Hopwood, P., Wonderling, D. E., Watson, M., Cull, A., Douglas, F., Cole, T. R. P., Eccles, D., Gray, J., Murday, V. A., Steel, M., et al. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602081 · Cited by 22
Effects of counseling Ashkenazi Jewish women about breast cancer risk.
Bowen, D. J., Burke, W., Culver, J. O., Press, N. A., & Crystal, S. R. (2006) · Cultural Diversity & Ethnic Minority Psychology · doi:10.1037/1099-9809.11.4.0 · Cited by 21
Geirdal, A. Ø., & Dahl, A. A. (2007) · Psycho-Oncology · doi:10.1002/pon.1198 · Cited by 20
Bennett, P. D., Wilkinson, C., Turner, J., et al. (2008) · Familial Cancer · doi:10.1007/s10689-008-9221-9 · Cited by 20
Kelly, K. M., Senter, L. A., Leventhal, H., Özakinci, G., & Porter, K. M. (2007) · Patient Education and Counseling · doi:10.1016/j.pec.2007.09.007 · Cited by 15
Brain, K. E., Parsons, E. P., Bennett, P. D., Cannings-John, R. L., & Hood, K. (2010) · Psycho-Oncology · doi:10.1002/pon.1807 · Cited by 12
Alamouti, R., Hachach‐Haram, N., & Farhadi, J. (2015) · European Journal of Plastic Surgery · doi:10.1007/s00238-015-1086-1 · Cited by 11
Albada, A., van Dulmen, S., Dijkstra, H., Wieffer, I., Witkamp, A. J., & Ausems, M. G. E. M. (2015) · Journal of Genetic Counseling · doi:10.1007/s10897-015-9869-x · Cited by 7
The Roter Interaction Analysis System (RIAS) in oncological consultations: psychometric properties
(1998) · Pure Amsterdam UMC · doi:10.1002/(sici)1099-1611(1998090)7:5
Cited by
[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures
Kashyap, D., Pal, D., Sharma, R., Garg, V. K., Goel, N., Koundal, D., Zaguia, A., Koundal, S., & Belay, A. (2022) · BioMed Research International · doi:10.1155/2022/9605439 · Cited by 529
RetractedScreening for Breast Cancer: US Preventive Services Task Force Recommendation Statement
US Preventive Services Task Force, Nicholson, W. K., Silverstein, M., Wong, J. B., Barry, M. J., Chelmow, D., Coker, T. R., Davis, E. M., Jaén, C. R., Krousel-Wood, M., et al. (2024) · JAMA · doi:10.1001/jama.2024.5534 · Cited by 463
Self-citationPersonalized early detection and prevention of breast cancer: ENVISION consensus statement
Pashayan, N., Antoniou, A. C., Ivanus, U., Esserman, L. J., Easton, D. F., French, D., Sroczynski, G., Hall, P., Cuzick, J., Evans, D. G., et al. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0388-9 · Cited by 438
Germline and Somatic Tumor Testing in Epithelial Ovarian Cancer: ASCO Guideline
Konstantinopoulos, P. A., Norquist, B., Lacchetti, C., Armstrong, D., Grisham, R. N., Goodfellow, P. J., Kohn, E. C., Levine, D. A., Liu, J. F., Lu, K. H., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02960 · Cited by 381
Germline Testing in Patients With Breast Cancer: ASCO–Society of Surgical Oncology Guideline
Bedrosian, I., Somerfield, M. R., Achatz, M. I., Boughey, J. C., Curigliano, G., Friedman, S., Kohlmann, W. K., Kurian, A. W., Laronga, C., Lynce, F., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02225 · Cited by 216
Metadata
- Authors
- US Preventive Services Task Force, Owens, D. K., Davidson, K. W., Krist, A. H., Barry, M. J., Cabana, M., Caughey, A. B., Doubeni, C. A., Epling, J. W., Kubik, M., Landefeld, C. S., Mangione, C. M., Pbert, L., Silverstein, M., Simon, M. A., Tseng, C.-W., & Wong, J. B.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2019-08-20
- Volume
- 322
- Issue
- 7
- Pages
- 652
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2969788639
- Cited by
- 467
- References
- 140
- FWCI
- 31.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.